<DOC>
	<DOCNO>NCT01912040</DOCNO>
	<brief_summary>Assessing 123 Iodine MIBG produce locally safety use clinical practice help patient management decision .</brief_summary>
	<brief_title>Study Of Safety Locally Manufactured 123I-metaiodobenzylguanidine ( MIBG ) Routine Clinical Use</brief_title>
	<detailed_description>We assess adverse reaction patient inject locally manufacture 123 Iodine MIBG . With monitor blood pressure heart rate follow injection potential immediate side effect .</detailed_description>
	<mesh_term>Iodine</mesh_term>
	<mesh_term>3-Iodobenzylguanidine</mesh_term>
	<criteria>Patients potential Adrenergic pathology Pregnant breast feeding female Hypersensitivity MIBG</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Safety profile</keyword>
	<keyword>locally produce 123 Iodine MIBG</keyword>
</DOC>